Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 32
1.
Mol Ther Nucleic Acids ; 35(2): 102165, 2024 Jun 11.
Article En | MEDLINE | ID: mdl-38571746

Duchenne muscular dystrophy (DMD) is the most prevalent herediatry disease in men, characterized by dystrophin deficiency, progressive muscle wasting, cardiac insufficiency, and premature mortality, with no effective therapeutic options. Here, we investigated whether adenine base editing can correct pathological nonsense point mutations leading to premature stop codons in the dystrophin gene. We identified 27 causative nonsense mutations in our DMD patient cohort. Treatment with adenine base editor (ABE) could restore dystrophin expression by direct A-to-G editing of pathological nonsense mutations in cardiomyocytes generated from DMD patient-derived induced pluripotent stem cells. We also generated two humanized mouse models of DMD expressing mutation-bearing exons 23 or 30 of human dystrophin gene. Intramuscular administration of ABE, driven by ubiquitous or muscle-specific promoters could correct these nonsense mutations in vivo, albeit with higher efficiency in exon 30, restoring dystrophin expression in skeletal fibers of humanized DMD mice. Moreover, a single systemic delivery of ABE with human single guide RNA (sgRNA) could induce body-wide dystrophin expression and improve muscle function in rotarod tests of humanized DMD mice. These findings demonstrate that ABE with human sgRNAs can confer therapeutic alleviation of DMD in mice, providing a basis for development of adenine base editing therapies in monogenic diseases.

2.
Nat Commun ; 15(1): 831, 2024 Jan 27.
Article En | MEDLINE | ID: mdl-38280857

Transposon-associated ribonucleoprotein TnpB is known to be the ancestry endonuclease of diverse Cas12 effector proteins from type-V CRISPR system. Given its small size (408 aa), it is of interest to examine whether engineered TnpB could be used for efficient mammalian genome editing. Here, we showed that the gene editing activity of native TnpB from Deinococcus radiodurans (ISDra2 TnpB) in mouse embryos was already higher than previously identified small-sized Cas12f1. Further stepwise engineering of noncoding RNA (ωRNA or reRNA) component of TnpB significantly elevated the nuclease activity of TnpB. Notably, an optimized TnpB-ωRNA system could be efficiently delivered in vivo with single adeno-associated virus (AAV) and corrected the disease phenotype in a tyrosinaemia mouse model. Thus, the engineered miniature TnpB system represents a new addition to the current genome editing toolbox, with the unique feature of the smallest effector size that facilitate efficient AAV delivery for editing of cells and tissues.


Gene Editing , Tyrosinemias , Mice , Animals , CRISPR-Cas Systems/genetics , Tyrosinemias/genetics , Tyrosinemias/therapy , Mammals
3.
Adv Sci (Weinh) ; 11(3): e2304113, 2024 Jan.
Article En | MEDLINE | ID: mdl-37984866

Mitochondrial base editing with DddA-derived cytosine base editor (DdCBE) is limited in the accessible target sequences and modest activity. Here, the optimized DdCBE tools is presented with improved editing activity and expanded C-to-T targeting scope by fusing DddA11 variant with different cytosine deaminases with single-strand DNA activity. Compared to previous DdCBE based on DddA11 variant alone, fusion of the activation-induced cytidine deaminase (AID) from Xenopus laevis not only permits cytosine editing of 5'-GC-3' sequence, but also elevates editing efficiency at 5'-TC-3', 5'-CC-3', and 5'-GC-3' targets by up to 25-, 10-, and 6-fold, respectively. Furthermore, the A-to-G editing efficiency is significantly improved by fusing the evolved DddA6 variant with TALE-linked deoxyadenosine deaminase (TALED). Notably, the authors introduce the reported high-fidelity mutations in DddA and add nuclear export signal (NES) sequences in DdCBE and TALED to reduce off-target editing in the nuclear and mitochondrial genome while improving on-target editing efficiency in mitochondrial DNA (mtDNA). Finally, these engineered mitochondrial base editors are shown to be efficient in installing mtDNA mutations in human cells or mouse embryos for disease modeling. Collectively, the study shows broad implications for the basic study and therapeutic applications of optimized DdCBE and TALED.


DNA, Mitochondrial , Gene Editing , Animals , Humans , Mice , DNA, Mitochondrial/genetics , Cytosine , Mutation , Mitochondria/genetics
4.
Mol Ther Nucleic Acids ; 33: 750-761, 2023 Sep 12.
Article En | MEDLINE | ID: mdl-37621413

Mutations in Rhodopsin (RHO) gene commonly cause autosomal dominant retinitis pigmentosa (adRP) without effective therapeutic treatment so far. Compared with genomic DNA-targeting CRISPR-Cas9 system, Cas13 edits RNA for therapeutic applications, avoiding the risk of causing permanent changes in the genome. In particular, a compact and high-fidelity Cas13X (hfCas13X) recently has been developed to degrade targeted RNA with minimal collateral effects and could also be packaged in a single adeno-associated virus for efficient in vivo delivery. In this study, we engineered single-guide RNA for hfCas13X to specifically knock down human mutant Rhodopsin transcripts RHO-P23H with minimal effect on wild-type transcripts. Moreover, treatment with hfCas13X alleviated the adRP progression in both RHO-P23H overexpression-induced and humanized hRHOP23H/WT mouse models. Our study indicates the potential of hfCas13X in treating adRP caused by RHO mutations and other genetic diseases.

7.
Protein Cell ; 14(6): 416-432, 2023 06 07.
Article En | MEDLINE | ID: mdl-37285261

Approximately 140 million people worldwide are homozygous carriers of APOE4 (ε4), a strong genetic risk factor for late onset familial and sporadic Alzheimer's disease (AD), 91% of whom will develop AD at earlier age than heterozygous carriers and noncarriers. Susceptibility to AD could be reduced by targeted editing of APOE4, but a technical basis for controlling the off-target effects of base editors is necessary to develop low-risk personalized gene therapies. Here, we first screened eight cytosine base editor variants at four injection stages (from 1- to 8-cell stage), and found that FNLS-YE1 variant in 8-cell embryos achieved the comparable base conversion rate (up to 100%) with the lowest bystander effects. In particular, 80% of AD-susceptible ε4 allele copies were converted to the AD-neutral ε3 allele in human ε4-carrying embryos. Stringent control measures combined with targeted deep sequencing, whole genome sequencing, and RNA sequencing showed no DNA or RNA off-target events in FNLS-YE1-treated human embryos or their derived stem cells. Furthermore, base editing with FNLS-YE1 showed no effects on embryo development to the blastocyst stage. Finally, we also demonstrated FNLS-YE1 could introduce known protective variants in human embryos to potentially reduce human susceptivity to systemic lupus erythematosus and familial hypercholesterolemia. Our study therefore suggests that base editing with FNLS-YE1 can efficiently and safely introduce known preventive variants in 8-cell human embryos, a potential approach for reducing human susceptibility to AD or other genetic diseases.


Apolipoprotein E4 , Cytosine , Humans , Apolipoprotein E4/genetics , Mutation , Blastocyst , Heterozygote , Gene Editing , CRISPR-Cas Systems
9.
Nat Biotechnol ; 41(8): 1080-1084, 2023 08.
Article En | MEDLINE | ID: mdl-36624150

Here we developed an adenine transversion base editor, AYBE, for A-to-C and A-to-T transversion editing in mammalian cells by fusing an adenine base editor (ABE) with hypoxanthine excision protein N-methylpurine DNA glycosylase (MPG). We also engineered AYBE variants enabling targeted editing at genomic loci with higher transversion editing activity (up to 72% for A-to-C or A-to-T editing).


Adenine , DNA Glycosylases , Animals , Adenine/metabolism , Gene Editing , DNA Repair/genetics , DNA Glycosylases/genetics , DNA Glycosylases/metabolism , Mammals
10.
Gene Ther ; 30(12): 801-806, 2023 Dec.
Article En | MEDLINE | ID: mdl-36721028

The conversion of non-neuronal cells to neurons is a promising potential strategy for the treatment of neurodegenerative diseases. Recent studies have reported that shRNA-, CasRx-, or ASO-mediated Ptbp1 suppression could reprogram resident astrocytes to neurons. However, some groups have disputed the interpretation of the data underlying the reported neuron conversion events. These controversies surrounding neuron conversion may be due to differences in the astrocyte fate-mapping systems. Here, we suppressed Ptbp1 using Cas13X and labelled astrocytes with an HA tag fused to Cas13X (Cas13X-NLS-HA). We found no astrocyte-to-neuron conversion in the mouse striatum via the HA-tagged labelling system compared with the GFAP-driven tdTomato labelling system (AAV-GFAP::tdTomato-WPRE) used in previous studies. Our findings indicate that Cas13X-mediated Ptbp1 knockdown failed to induce neuron conversion in vivo.


Astrocytes , Neurons , Mice , Animals , Heterogeneous-Nuclear Ribonucleoproteins/genetics , Polypyrimidine Tract-Binding Protein/genetics
11.
J Clin Invest ; 133(3)2023 02 01.
Article En | MEDLINE | ID: mdl-36512423

Approximately 10% of monogenic diseases are caused by nonsense point mutations that generate premature termination codons (PTCs), resulting in a truncated protein and nonsense-mediated decay of the mutant mRNAs. Here, we demonstrate a mini-dCas13X-mediated RNA adenine base editing (mxABE) strategy to treat nonsense mutation-related monogenic diseases via A-to-G editing in a genetically humanized mouse model of Duchenne muscular dystrophy (DMD). Initially, we identified a nonsense point mutation (c.4174C>T, p.Gln1392*) in the DMD gene of a patient and validated its pathogenicity in humanized mice. In this model, mxABE packaged in a single adeno-associated virus (AAV) reached A-to-G editing rates up to 84% in vivo, at least 20-fold greater than rates reported in previous studies using other RNA editing modalities. Furthermore, mxABE restored robust expression of dystrophin protein to over 50% of WT levels by enabling PTC read-through in multiple muscle tissues. Importantly, systemic delivery of mxABE by AAV also rescued dystrophin expression to averages of 37%, 6%, and 54% of WT levels in the diaphragm, tibialis anterior, and heart muscle, respectively, as well as rescued muscle function. Our data strongly suggest that mxABE-based strategies may be a viable new treatment modality for DMD and other monogenic diseases.


Muscular Dystrophy, Duchenne , Animals , Mice , CRISPR-Cas Systems , Disease Models, Animal , Dystrophin/genetics , Gene Editing/methods , Genetic Therapy/methods , Muscle, Skeletal/metabolism , Muscular Dystrophy, Duchenne/genetics , Muscular Dystrophy, Duchenne/therapy , RNA Editing , Humans
12.
Nat Biotechnol ; 41(1): 108-119, 2023 01.
Article En | MEDLINE | ID: mdl-35953673

CRISPR-Cas13 systems have recently been used for targeted RNA degradation in various organisms. However, collateral degradation of bystander RNAs has limited their in vivo applications. Here, we design a dual-fluorescence reporter system for detecting collateral effects and screening Cas13 variants in mammalian cells. Among over 200 engineered variants, several Cas13 variants including Cas13d and Cas13X exhibit efficient on-target activity but markedly reduced collateral activity. Furthermore, transcriptome-wide off-targets and cell growth arrest induced by Cas13 are absent for these variants. High-fidelity Cas13 variants show similar RNA knockdown activity to wild-type Cas13 but no detectable collateral damage in transgenic mice or adeno-associated-virus-mediated somatic cell targeting. Thus, high-fidelity Cas13 variants with minimal collateral effects are now available for targeted degradation of RNAs in basic research and therapeutic applications.


CRISPR-Cas Systems , RNA , Animals , Mice , CRISPR-Cas Systems/genetics , RNA/genetics , RNA Stability/genetics , Mice, Transgenic , Transcriptome , Mammals/genetics
13.
Nanomaterials (Basel) ; 12(16)2022 Aug 20.
Article En | MEDLINE | ID: mdl-36014736

Controlling defects and interfaces in composite absorbers can effectively regulate electromagnetic (EM) parameters and enhance the electromagnetic wave (EMW) absorption ability, but the mechanism still needs to be further elucidated. In this study, ZnFe2O4/ZnO/C composite was synthesized via the hydrothermal method followed by post-annealing in different atmospheres. Defects and interfaces were characterized by Raman, PL spectroscopy, XPS and TEM, and their relationship with dielectric loss and EMW absorption performance was discussed in detail. Results show that the N2-annealed ZnFe2O4/ZnO/C composite with abundant defects and interfaces as well as an optimized composition exhibits excellent EMW dissipation ability, with a RLmin value of -17.4 dB and an fe of 3.85 GHz at a thickness of 2.28 mm. The excellent EMW absorption performance originates from suitable impedance matching, significant conduction loss and strong dielectric loss (interfacial polarization, diploe polarization and defect polarization) dominated by lattice defects and interfaces. This study provides a view into the relationship between defects, interfaces, EM parameters and EMW absorption ability, and also suggests an effective way to promote EMW dissipation ability of the absorbers by controlling defects and interfaces.

14.
Sci Transl Med ; 14(654): eabn0449, 2022 07 20.
Article En | MEDLINE | ID: mdl-35857824

Programmable RNA editing tools enable the reversible correction of mutant transcripts, reducing the potential risk associated with permanent genetic changes associated with the use of DNA editing tools. However, the potential of these RNA tools to treat disease remains unknown. Here, we evaluated RNA correction therapy with Cas13-based RNA base editors in the myosin VI p.C442Y heterozygous mutation (Myo6C442Y/+) mouse model that recapitulated the phenotypes of human dominant-inherited deafness. We first screened several variants of Cas13-based RNA base editors and guide RNAs (gRNAs) targeting Myo6C442Y in cultured cells and found that mini dCas13X.1-based adenosine base editor (mxABE), composed of truncated Cas13X.1 and the RNA editing enzyme adenosine deaminase acting on RNA 2 deaminase domain variant (ADAR2ddE488Q), exhibited both high efficiency of A > G conversion and low frequency of off-target edits. Single adeno-associated virus (AAV)-mediated delivery of mxABE in the cochlea corrected the mutated Myo6C442Y to Myo6WT allele in homozygous Myo6C442Y/C442Y mice and resulted in increased Myo6WT allele in the injected cochlea of Myo6C442Y/+ mice. The treatment rescued auditory function, including auditory brainstem response and distortion product otoacoustic emission up to 3 months after AAV-mxABE-Myo6 injection in Myo6C442Y/+ mice. We also observed increased survival rate of hair cells and decreased degeneration of hair bundle morphology in the treated compared to untreated control ears. These findings provide a proof-of-concept study for RNA editing tools as a therapeutic treatment for various semidominant forms of hearing loss and other diseases.


Deafness , Hearing Loss , Animals , Mice , Genes, Dominant , Hair Cells, Auditory , Hearing Loss/genetics , Hearing Loss/therapy , RNA
18.
Sci Prog ; 104(2): 368504211026157, 2021.
Article En | MEDLINE | ID: mdl-34191643

The high-pressure common rail system has been widely used owing to its precise control of fuel injection rate profile, which plays a decisive role in cylinder combustion, atomization, and emission. The fuel injection rate profile of high-pressure common rail system was studied, and a fuel injection rate profile calculation model is proposed. The model treats the injector as a black box. Some measured data are needed to calculate the parameters in the model. The rise and fall of injection rate is regarded as trigonometric function to reduce the complexity and increase the accuracy. The model was verified using two different types of fuel injectors. The model calculation results were evaluated under various data input conditions. The results show that the model has good applicability to different input data and injectors. In addition, because the model building requires a large amount of experimental data, a comprehensive analysis of various input data was also conducted. The injection profile was analyzed from a new perspective and the regularity of injection rate profile was established.

19.
Nat Methods ; 18(5): 499-506, 2021 05.
Article En | MEDLINE | ID: mdl-33941935

Competitive coevolution between microbes and viruses has led to the diversification of CRISPR-Cas defense systems against infectious agents. By analyzing metagenomic terabase datasets, we identified two compact families (775 to 803 amino acids (aa)) of CRISPR-Cas ribonucleases from hypersaline samples, named Cas13X and Cas13Y. We engineered Cas13X.1 (775 aa) for RNA interference experiments in mammalian cell lines. We found Cas13X.1 could tolerate single-nucleotide mismatches in RNA recognition, facilitating prophylactic RNA virus inhibition. Moreover, a minimal RNA base editor, composed of engineered deaminase (385 aa) and truncated Cas13X.1 (445 aa), exhibited robust editing efficiency and high specificity to induce RNA base conversions. Our results suggest that there exist untapped bacterial defense systems in natural microbes that can function efficiently in mammalian cells, and thus potentially are useful for RNA-editing-based research.


CRISPR-Cas Systems , RNA Editing , RNA, Bacterial , Animals , Bacterial Proteins , Cell Line , Cloning, Molecular , Databases, Nucleic Acid , Dogs , Humans , Mice , RNA Interference
20.
Sci Prog ; 104(1): 36850420983625, 2021.
Article En | MEDLINE | ID: mdl-33438521

High pressure common rail system can precisely control the injection time and injection pressure to improve the thermal efficiency of the engine. The injection characteristics of the system can affect the combustion and emission process of the engine. Injection stability is defined as variation characteristics of injection. This could have an unignored influence on combustion and engine output, while few study has been published. The primary objective is to establish evaluation systems and methods for injection stability. Then to study injection stability of the high pressure common rail system. Firstly, several parameters that have an important influence on the emission and combustion are identified. Based on the characteristics data obtained, it is verified that the stability parameters are in accordance with the normal distribution. Then, the five characteristic stability parameters of close speed of injection, cycle injection mass, injection delay, maximum injection rate and open speed of injection were quantitatively analyzed by using range, relative range, kurtosis and variance. It is found that the close speed of injection is greatly depend on injection pressure, the range of close speed varies from 1.8 to 5.1 mg/ms when rail pressure varies from 60 MPa to 160 MPa at 0.6 ms energizing time. The stability of injection mass depends on energizing time, the relative range in short energizing time can be four times than long energizing time. The maximum injection rate has similar characteristics with injection mass, it is also depends on energizing time. The range of maximum injection rate is reduced from the average of 0.6-0.7 mg/ms to 0.3 or even 0.2 mg/ms with the increase of energizing time. The injection delay and open speed of injection seems to be greatly affected by pressure fluctuation, since the observed data present complex rules. Pressure fluctuation in common rail can affect injection stability a lot.

...